SBS STRATEC SE

DGAP-News: STRATEC SE APPOINTS NEW SUPERVISORY BOARD CHAIR

DGAP-News: STRATEC SE / Key word(s): Personnel
STRATEC SE APPOINTS NEW SUPERVISORY BOARD CHAIR

26.11.2020 / 16:19
The issuer is solely responsible for the content of this announcement.

STRATEC SE APPOINTS NEW SUPERVISORY BOARD CHAIR

Birkenfeld, November 26, 2020

At its meeting today, the Supervisory Board of STRATEC SE elected Prof. Dr. Stefanie Remmele as the new Chairwoman of the Supervisory Board as of November 26, 2020. Prof. Dr. Remmele is Professor of Medical Technology at Landshut University of Applied Sciences and has been a member of the Supervisory Board at STRATEC SE since 2014. "We are delighted to have gained Prof. Dr. Remmele for the role of the Chairwoman of the Supervisory Board and look forward to continuing our strong and successful working relationship", comments Dr. Rolf Vornhagen, Supervisory Board member at STRATEC SE.

Prof. Dr. Stefanie Remmele will succeed the previous Chair, Dr. Frank Hiller. Given the recommendations made in the new version of the German Corporate Governance Code, Dr. Hiller, who is CEO of DEUTZ AG, Cologne, will in future be Deputy Chair of the Supervisory Board. The management would like to thank Dr. Hiller for his great commitment to the STRATEC Group in his role as Chairman of the Supervisory Board. "We are very pleased that Dr. Hiller will continue to contribute his expertise and accompany the board closely in future as well", adds Dr. Rolf Vornhagen.

ABOUT STRATEC
STRATEC SE () designs and manufactures fully automated analyzer systems for its partners in the fields of clinical diagnostics and biotechnology. Furthermore, the company offers complex consumables for diagnostic and medical applications. STRATEC covers the entire value chain - from development to design and production through to quality assurance.

The partners market the systems, software, and consumables, in general together with their own reagents, as system solutions to laboratories, blood banks and research institutes around the world. STRATEC develops its products on the basis of its own patented technologies.

Shares in the company (ISIN: DE000STRA555) are traded in the Prime Standard segment of the Frankfurt Stock Exchange and are listed in the SDAX select index of the German Stock Exchange.

FURTHER INFORMATION IS AVAILABLE FROM:
STRATEC SE
Jan Keppeler | Investor Relations & Corporate Communications
Tel: 515
Fax: 190


26.11.2020 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at

Language: English
Company: STRATEC SE
Gewerbestr. 37
75217 Birkenfeld
Germany
Phone: +49 (0)7082 7916 0
Fax: +49 (0)7082 7916 999
E-mail:
Internet:
ISIN: DE000STRA555
WKN: STRA55
Indices: SDAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 1150866

 
End of News DGAP News Service

1150866  26.11.2020 

fncls.ssp?fn=show_t_gif&application_id=1150866&application_name=news&site_id=research_pool
EN
26/11/2020

Underlying

SBSSTRATEC SE

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on STRATEC SE

Andreas Riemann ... (+3)
  • Andreas Riemann
  • Jean Danjou
  • Usama Tariq
ALESK ESKER SA
OSE OSE Immunothera... ... (+24)

ODDO BHF Small & MIDCAP MORNING NEWS - 03/28/2024

With the exception of the US, construction markets should continue to shrink in 2024 (-2% in Europe) before rebounding on the back of lower interest rates. Against this backdrop, groups will be differentiated mainly on the basis of their resilience (geographical and price/cost mix), capital allocation (and special situations) and valuation. In this context, we are upgrading our recommendations on KONE (modernisation as an alternative source of growth to China) and Holcim (a substantia...

ALESK ESKER SA
OSE OSE IMMUNOTHERAPEUTICS SA
ZIL2 ELRINGKLINGER AG
SBS STRATEC SE
F3C SFC ENERGY AG
HCO HIGHCO SA
CGM CEGEDIM SA
VRAP VRANKEN-POMMERY MONOPOLE SA
LNA LNA SANTE SA
TRI TRIGANO SA
BCP BANCO COMERCIAL PORTUGUES S.A.
QDT QUADIENT SA
SESL SES-IMAGOTAG SA
BEZ BERENTZEN GRUPPE
ALBFR SIDETRADE SA
SMHN SUESS MICROTEC AG
JUN3 JUNGHEINRICH AG PREF
S92 SMA SOLAR TECHNOLOGY AG
RBO ROCHE BOBOIS INTERNATIONAL SAS
JEN JENOPTIK AG
KTA KNAUS TABBERT
INPST INPOST S.A.
MRX MISTER SPEX SE
LHYFE LHYFE S.A.
03/28/24 March 28, 2024 1 EN
Andreas Riemann ... (+3)
  • Andreas Riemann
  • Jean Danjou
  • Usama Tariq
ALESK ESKER SA
OSE OSE Immunothera... ... (+26)

ODDO BHF Small & MIDCAP MORNING NEWS - 28/03/2024

Hormis les Etats-Unis, les marchés de la construction devraient continuer à reculer en 2024 (-2% en Europe) avant de rebondir à la faveur d’une baisse des taux. Dans ce contexte, la différenciation entre les groupes se fera essentiellement sur leur capacité de résistance (mix géographique et prix/ coûts), l’allocation du capital (et situations spéciales) et leur valorisation. Face à cet environnement, nous relevons nos recommandations sur KONE (la modernisation comme relais de la Chin...

ALESK ESKER SA
OSE OSE IMMUNOTHERAPEUTICS SA
ZIL2 ELRINGKLINGER AG
SBS STRATEC SE
TNG TRANSGENE SA
F3C SFC ENERGY AG
HCO HIGHCO SA
CGM CEGEDIM SA
NTG NETGEM SA
VRAP VRANKEN-POMMERY MONOPOLE SA
LNA LNA SANTE SA
TRI TRIGANO SA
BCP BANCO COMERCIAL PORTUGUES S.A.
QDT QUADIENT SA
SESL SES-IMAGOTAG SA
BEZ BERENTZEN GRUPPE
ALBFR SIDETRADE SA
SMHN SUESS MICROTEC AG
JUN3 JUNGHEINRICH AG PREF
S92 SMA SOLAR TECHNOLOGY AG
RBO ROCHE BOBOIS INTERNATIONAL SAS
JEN JENOPTIK AG
KTA KNAUS TABBERT
INPST INPOST S.A.
MRX MISTER SPEX SE
LHYFE LHYFE S.A.
03/28/24 March 28, 2024 1 FR
Oliver Metzger
  • Oliver Metzger
SBS STRATEC SE

STRATEC SE : FY review – Sequential improvement, but guidance looks we...

>Top line with positive momentum, but below expectations - Stratec’s Q4 2023 revenues of € 74.2m (+10.8% y-o-y) profited from +12.9% growth in constant currencies), which were 4%/3% below our and the consensus’ expectations. The consolidation of Natech Plastics contributed around 500bp to revenues growth. We like that the company has returned to organic growth in the last quarter, albeit less pronounced than anticipated.Bottom line with sequential growth ...

03/28/24 March 28, 2024 1 EN
 PRESS RELEASE
Free
SBS STRATEC SE

EQS-News: STRATEC BERICHTET ZAHLEN FÜR DAS GESCHÄFTSJAHR 2023

EQS-News: STRATEC SE / Schlagwort(e): Jahresergebnis STRATEC BERICHTET ZAHLEN FÜR DAS GESCHÄFTSJAHR 2023 28.03.2024 / 06:55 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. STRATEC BERICHTET ZAHLEN FÜR DAS GESCHÄFTSJAHR 2023 Konzernumsatz 2023 währungsbereinigt -3,8% auf 261,9 Mio. € (2022: 274,6 Mio. €);  Währungsbereinigt +12,9% in Q4/2023 Adjustierte EBIT-Marge mit 10,3% (2022: 16,4%) im Bereich des Prognosekorridors Neue Produkteinführung und neu geschlossene Entwicklungskooperationen mit Partnern Ausblick für 2024: Währungsbe...

March 28, 2024 1 DE
 PRESS RELEASE
Free
SBS STRATEC SE

EQS-News: STRATEC REPORTS RESULTS FOR 2023 FINANCIAL YEAR

EQS-News: STRATEC SE / Key word(s): Annual Results STRATEC REPORTS RESULTS FOR 2023 FINANCIAL YEAR 28.03.2024 / 06:55 CET/CEST The issuer is solely responsible for the content of this announcement. STRATEC REPORTS RESULTS FOR 2023 FINANCIAL YEAR Consolidated sales in 2023 -3.8% at constant currency to € 261.9 million (2022: € 274.6 million); Constant-currency growth of 12.9% in Q4/2023 Adjusted EBIT margin of 10.3% (2022: 16.4%) within guidance corridor New product launch and newly concluded development cooperations with partners 2024 guidance: Sales on a constant-cu...

March 28, 2024 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch